Two Sigma Investments’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Two Sigma Investments’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Buy	8,528 +4,128	+94%	+$120K	﹤0.01%	4167
2025 Q4	$128K	Sell	4,400 -16	-0.4%	-$321	﹤0.01%	3835
2025 Q3	$74K	Buy	+4,416	New	+$144K	﹤0.01%	3507
2021 Q4	–	Sell	-90	Closed	-$113K	–	4941
2021 Q3	$113K	Buy	90 +38	+73%	+$73.7K	﹤0.01%	4071
2021 Q2	$165K	Sell	52 -279	-84%	-$1.1M	﹤0.01%	3831
2021 Q1	$2.04M	Buy	331 +74	+29%	+$537K	0.01%	1694
2020 Q4	$1.46M	Buy	257 +167	+186%	+$1.05M	﹤0.01%	1717
2020 Q3	$540K	Sell	90 -50	-36%	-$292K	﹤0.01%	2187
2020 Q2	$873K	Buy	+140	New	+$948K	﹤0.01%	1624
2019 Q3	–	Sell	-7	Closed	-$156K	–	3834
2019 Q2	$156K	Buy	7 +4	+133%	+$99K	﹤0.01%	3135
2019 Q1	$85K	Sell	3 -9	-75%	-$216K	﹤0.01%	2912
2018 Q4	$172K	Sell	12 -19	-61%	-$425K	﹤0.01%	2743
2018 Q3	$1.1M	Buy	+31	New	+$957K	﹤0.01%	1905

Other funds holding YARW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments's YARW Position: Q1 2026 in Review

Two Sigma Investments increased its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 94% in Q1 2026, buying an estimated $120K and bringing the position to 8,528 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #4167.

Two Sigma Investments first reported a position in YARW in Q3 2018 and has held it in 13 quarters since. The position peaked at $2.04M in Q1 2021. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

Two Sigma Investments held 8,528 shares of Yarrow Bioscience, Inc. Common Stock worth $255K as of Q1 2026.
Two Sigma Investments bought 4,128 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $120K.
Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4167 holding.
Two Sigma Investments first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2018 and has held it in 13 quarters since.
Two Sigma Investments's Yarrow Bioscience, Inc. Common Stock position peaked at $2.04M in Q1 2021.
42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.